These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 33785338)
1. GALNT2 promotes cell proliferation, migration, and invasion by activating the Notch/Hes1-PTEN-PI3K/Akt signaling pathway in lung adenocarcinoma. Wang W; Sun R; Zeng L; Chen Y; Zhang N; Cao S; Deng S; Meng X; Yang S Life Sci; 2021 Jul; 276():119439. PubMed ID: 33785338 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis. Lu C; Shan Z; Hong J; Yang L Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966 [TBL] [Abstract][Full Text] [Related]
3. Agmatinase promotes the lung adenocarcinoma tumorigenesis by activating the NO-MAPKs-PI3K/Akt pathway. Zhu HE; Yin JY; Chen DX; He S; Chen H Cell Death Dis; 2019 Nov; 10(11):854. PubMed ID: 31699997 [TBL] [Abstract][Full Text] [Related]
4. PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma. Gao Y; Luo L; Xie Y; Zhao Y; Yao J; Liu X Mol Carcinog; 2020 May; 59(5):503-511. PubMed ID: 32133692 [TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of celastrol by inhibition of proliferation, invasion, and migration in cholangiocarcinoma via PTEN/PI3K/Akt pathway. Zhu B; Wei Y Cancer Med; 2020 Jan; 9(2):783-796. PubMed ID: 31957323 [TBL] [Abstract][Full Text] [Related]
6. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway. Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133 [TBL] [Abstract][Full Text] [Related]
7. Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway. Liang J; Li H; Han J; Jiang J; Wang J; Li Y; Feng Z; Zhao R; Sun Z; Lv B; Tian H Cell Death Dis; 2020 Aug; 11(8):614. PubMed ID: 32792503 [TBL] [Abstract][Full Text] [Related]
8. GALNT2/14 overexpression correlate with prognosis and methylation: potential therapeutic targets for lung adenocarcinoma. Yu Y; Wang Z; Zheng Q; Li J Gene; 2021 Jul; 790():145689. PubMed ID: 33964375 [TBL] [Abstract][Full Text] [Related]
9. miR-186-5p promotes cell growth, migration and invasion of lung adenocarcinoma by targeting PTEN. Feng H; Zhang Z; Qing X; French SW; Liu D Exp Mol Pathol; 2019 Jun; 108():105-113. PubMed ID: 30981721 [TBL] [Abstract][Full Text] [Related]
10. Loss of ARID1A expression promotes lung adenocarcinoma metastasis and predicts a poor prognosis. Sun D; Zhu Y; Zhao H; Bian T; Li T; Liu K; Feng L; Li H; Hou H Cell Oncol (Dordr); 2021 Oct; 44(5):1019-1034. PubMed ID: 34109546 [TBL] [Abstract][Full Text] [Related]
11. Actin-like protein 8 promotes cell proliferation, colony-formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells. Ma S; Wang X; Zhang Z; Liu D Thorac Cancer; 2020 Mar; 11(3):526-536. PubMed ID: 31962007 [TBL] [Abstract][Full Text] [Related]
12. CAPN1 promotes malignant behavior and erlotinib resistance mediated by phosphorylation of c-Met and PIK3R2 via degrading PTPN1 in lung adenocarcinoma. Chen Y; Tang J; Lu T; Liu F Thorac Cancer; 2020 Jul; 11(7):1848-1860. PubMed ID: 32395869 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN. Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551 [TBL] [Abstract][Full Text] [Related]
14. DUS4L suppresses invasion and metastasis in LUAD via modulation of PI3K/AKT and ERK/MAPK signaling through GRB2. Li Z; Zhao PL; Gao X; Li X; Meng YQ; Li ZQ; Zhai KR; Wei SL; Feng HM; Huang HR; Li B Int Immunopharmacol; 2024 Dec; 142(Pt A):113043. PubMed ID: 39216120 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of FYN suppresses the epithelial-to-mesenchymal transition through down-regulating PI3K/AKT pathway in lung adenocarcinoma. Xue F; Jia Y; Zhao J Surg Oncol; 2020 Jun; 33():108-117. PubMed ID: 32561075 [TBL] [Abstract][Full Text] [Related]
16. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway. Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942 [TBL] [Abstract][Full Text] [Related]
17. Targeting PRMT5/Akt signalling axis prevents human lung cancer cell growth. Zhang S; Ma Y; Hu X; Zheng Y; Chen X J Cell Mol Med; 2019 Feb; 23(2):1333-1342. PubMed ID: 30461193 [TBL] [Abstract][Full Text] [Related]
18. IGF2BP3 aggravates lung adenocarcinoma progression by modulation of PI3K/AKT signaling pathway. Chen X; Zhu X; Shen X; Liu Y; Fu W; Wang B Immunopharmacol Immunotoxicol; 2023 Jun; 45(3):370-377. PubMed ID: 36972188 [TBL] [Abstract][Full Text] [Related]
19. MiR-340-3p-HUS1 axis suppresses proliferation and migration in lung adenocarcinoma cells. Ren K; Yu Y; Wang X; Liu H; Zhao J Life Sci; 2021 Jun; 274():119330. PubMed ID: 33711383 [TBL] [Abstract][Full Text] [Related]
20. Upregulation of sine oculis homeobox homolog 3 is associated with proliferation, invasion, migration, as well as poor prognosis of esophageal cancer. Du J Anticancer Drugs; 2019 Jul; 30(6):596-603. PubMed ID: 30672777 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]